This updated analysis on the smart inhalers market by Persistence Market Research predicts the industry to surge ahead at a CAGR of 23.5% and attain a net worth of US$ 1 Bn by the end of the decade.
Respiratory disorders such as asthma and COPD have become more frequent over the past decade, and this trend is expected to be followed through this decade as well. With more instances of respiratory issues being recorded, demand for treatment and therapies for these disorders has also subsequently risen.
The adoption of smart inhalers is expected to rise as more healthcare professionals recommend them and their efficiency in drug delivery and drug tracking is realized. Increased medical adherence, reduced costs of treatment, improved and better results, and ability to track and maintain a record of clinical data are some of the factors that are expected to propel the adoption of smart inhalers.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/26881
Key manufacturers of smart inhalers are investing in reaching out to untapped markets and are focusing on increasing product awareness. They are also adopting organic as well as inorganic strategies to boost sales across regions.
In July 2019, Teva Pharmaceutical, a renowned pharmaceutical firm, announced that it has achieved FDA approval for its AirDuo Digihaler. The product is a sensor-enabled inhaler that sends usage data to a smartphone, and this information can also be shared with a medical provider.
In May 2021, RYAH Medtech Inc. signed an agreement with exclusive product distribution and software development rights to its French partner, Delled SAS, for the RYAH smart inhaler.
Company Profiles:
OPKO Health, Inc.
AstraZeneca plc
GlaxoSmithKline
Propeller Health
Aptar Pharma
Novartis AG
Boehringer Ingelheim
Teva Pharmaceuticals
H&T Presspart Manufacturing Ltd.
Sensirion AG
Cohero Health, Inc.
Others.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/26881
Key Takeaways from Market Study
The smart inhalers industry is predicted to expand at an impressive CAGR of 23.5% through 2031.
The market in China is expected to rise at the fastest pace through 2031.
The adoption of smart inhalers in North America is high and the market in this region accounts for a dominant share in the global landscape.
Lack of awareness in underdeveloped economies is a major restraining factor for market growth.
By 2031, the global smart inhalers market is predicted to be worth over US$ 1 Bn.
Increased medical adherence, the rising proliferation of technology in the medical industry, and growing awareness about the benefits of smart inhalers are some of the factors that favor market growth potential.
To utilize the full revenue potential of the market, smart inhaler manufacturers would have to increase awareness and adoption of the product in developing regions, says a Persistence Market Research analyst.
Competitive Landscape
The global market for smart inhalers has been identified as a fairly fragmented space due to the presence of a high number of market participants.
Some of the key market players included in the report are GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca plc, Boehringer Ingelheim International GmbH, Aptar Pharma (AptarGroup, Inc.), Propeller Health, OPKO Health Inc., H&T Presspart Manufacturing Ltd., Sensirion AG, and Cohero Health Inc.
The above are identified as key suppliers of smart inhalers. These market participants are engaged in market expansion activities and are focusing on mergers and collaborations to develop a better product portfolio and drive their sales funnel.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/26881
More Valuable Insights on Offer
Persistence Market Research, a research and consulting firm, has published a new market research report on the global smart inhalers market that contains industry analysis of 20162020 and opportunity assessment for 20212031.
The report provides an in-depth analysis of the market through different segments, namely, product type, disease indication, distribution channel, and region. The report also provides supply and demand trends along with an overview of the parent market.-
Access Related Reports-
Nebulizer devises Market-
Global Nebulizer Devices Market is projected to rise to a valuation of over US$ 3,382 Mn by the end of 2025 from a valuation of around US$ 2,033 Mn in 2017.
Noninvasive Ventilation Masks And Circuits Market-
The global Noninvasive Ventilation Masks And Circuits Market was valued at US$ 2.4 Bn in 2019 and is expected to progress at a CAGR of more than 9% during the forecast period (20202030).
Airway Clearance System Market-
According to the report, the global airway cleaner systems market is projected to exhibit a CAGR of 7.6% from 2017 to 2025. Rising from a valuation of US$ 434.0 Mn in 2016, the market is expected to reach a valuation of US$ 838.7 Mn by the end of 2025.
Continuous Positive Airway Pressure CPAP Devices Market-
The global continuous positive airway pressure devices market is expected to witness a CAGR of more than 6% during the forecast period (20202030).
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact Us:
Persistence Market Research
Address 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. +1-646-568-7751
USA-Canada Toll-free +1 800-961-0353
Sales sales@persistencemarketresearch.com
